4.0
15 Nov 2022
Former employee, more than 1 year
San Diego, CA
Recommend
CEO approval
Business outlook
Pros
Dexcom is the industry leader and primary patent owner for Continuous Glucose Monitoring (CGM) apparatuses and is well poised for continued growth which means both job security and good prospects for stock price increases over time.
Cons
No shortage of work, especially within the Finance Org, which leads to little to no downtime and burnout.